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Purpose: The main objective of this study is to determine the anti-inflammatory effect of topical amniotic membrane
(AM) suspension on corneal alkali burn compared to topical serum eyedrops.
Methods: Thirty eyes from 30 Sprague-Dawley male rats were used. After alkali injuries using 1 N NaOH, the control
group (n=10) received topical PBS four times a day for 2 days. The first study group received topical 30% AM suspension,
and the second study group (n=10) received topical 30% rat serum. Using slit lamp biomicroscopy, injured corneas were
evaluated and scored in terms of re-epithelialization, corneal opacity, and neovascularization (NV). Tissue sections were
analyzed histologically for cellular infiltration, and immunohistochemical staining was conducted using rat anti-mouse
F4/80 antibody for the detection of macrophages.
Results: In the inflammatory wound healing model, the epithelial healing ratios of the control group, the AM suspension
group, and the serum eyedrop group were 1.8±15.1%, 34.1±17.7%, and 41.5±16.1%, respectively (p<0.0001). The opacity
scores for the control group, the AM suspension group, and the serum eyedrop group 48 h after the insult were 4.8±0.5,
3.4±0.5, and 3.0±0.8, respectively, showing a significant difference (p<0.0001). Moreover, the NV scores for the control
group, AM suspension group, and serum eyedrop group 48 h after the insult were 5.8±0.9, 4.0±1.3, and 4.3±0.9 (p=0.006).
Upon immunohistochemical evaluation using F4/80, significantly fewer F4/80+ cells were recruited in the AM suspension
and serum eyedrop groups than the control group (p=0.027).
Conclusions: The suspension form of the amniotic membrane promoted epithelial healing and reduced corneal opacity
and NV in alkali burn. It also suppressed F4/80 expression in the corneal stroma, indicating that the AM suspension
maintains its beneficial biochemical effect on inflammatory corneal wound healing in vivo.
The ocular surface and associated adnexal structures are
currently recognized to form an integrated functional unit that
is critically important for optical clarity, vision, protection,
and ocular health [1]. These substructures interact with one
another and participate actively in the defense of the ocular
surface through immune cells and via cytokine release. Failure
of this ocular surface can occur in a broad range of clinical
conditions,  with  differing  pathogeneses;  a  variety  of
endogenous and exogenous precipitating factors, the most
common  of  which  are  chemical  trauma,  infection,
inflammation, and hereditary conditions; or secondary ocular
surface failure [2]. Some researchers have recently proposed
that  the  mechanisms  underlying  neurogenic  inflammation
may involve the local release of neuromediators in diseases
such as allergic conjunctivitis and dry eye; this phenomenon
may  also  play  a  pivotal  role  in  both  the  initiation  of  the
immune response and the regulation of the chronicity of the
inflammatory response [3]. Thus, in the treatment of ocular
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surface disease, anti-inflammatory effects, as well as rapid
epithelialization, would be critical.
The use of amniotic membrane (AM) as a graft for ocular
surface  reconstruction  was  initially  reported  by  Kim  and
Tseng  in  1995  [4],  and  the  popularity  of  this  surgical
procedure  has  increased  in  recent  years.  It  has  been
determined that the transplantation of AM as a temporary or
permanent graft promotes epithelial wound healing and exerts
potent  anti-inflammatory  and  antiscarring  effects  on  the
ocular surface [1,5]. However, despite the valuable effects of
AM,  the  clinical  application  of  AM  transplantation  is
currently limited to severe cases of ocular surface disease, as
these tend to require an invasive surgical procedure that may
result  in  a  variety  of  suture-related  complications  [6].
Additionally,  the  biochemical  effect  of  AM  may  not  be
maintained continuously following AM transplantation. In
this regard, if the suspension type of AM is provided and
retains its own beneficial effect, it may prove valuable in the
treatment of ocular surface disease, as AM has been shown to
promote  corneal  epithelialization  and  to  suppress
inflammation on the ocular surface.
The principal objective of this study was to determine the
anti-inflammatory effects of a topical AM suspension on a
corneal alkali burn relative to topical serum eyedrops.
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404METHODS
Amniotic membrane suspension preparation: In accordance
with the tenets laid out in the Declaration of Helsinki and after
having properly acquired informed consent, human AM was
obtained during elective cesarean deliveries and processed as
reported in a prior study [7]. In brief, AM was obtained from
the placenta, which exhibited negative serological test results
for the human immunodeficiency virus, hepatitis B and C
viruses, and syphilis. The placentas were maintained in sterile
plastic bags on ice during transfer, and were handled via sterile
techniques  at  all  times.  Under  a  lamellar-flow  hood,  the
placentas were rinsed several times to remove excessive blood
clots,  with  0.9%  normal  saline  containing  50  μg/ml  of
penicillin, 50 μg/ml of streptomycin, 100 μg/ml of neomycin,
and 2.5 μg/ml of amphotericin B. The AM was separated from
the remaining chorion via blunt dissection with two sets of
forceps while immersed in the above-mentioned antibiotic-
containing Earle’s balanced salt solution (Gibco BRL Life
Technologies, Gaithersburg, MD). After being separated from
the  chorion,  the  AM  was  sliced  into  smaller  pieces  with
Stevens scissors.
The methods for extraction of the proteins from the AM
are as given below. First, employing sterile techniques, a
homogenizer  was  used.  After  grinding  the  membrane,  a
sonicator  was  applied  for  additional  protein  extraction.
Finally,  the  liquefied  AM  suspension  was  lyophilized  to
prevent damage to the AM suspension due to a prolonged
preservation period and to maintain the bioactivity of the
suspension.
The  powdered  AM  was  dissolved  with  Dulbecco's
Modified  Eagle  Medium:  F-12  medium  (1:1;  Jeil
Biotechservices Inc., Daegu, ROK) and centrifuged for 10
min at 9,300× g. The supernatant was then separated carefully
and diluted to 30% with PBS (Amgen, Thousand Oaks, CA).
Rat serum preparation: Rat serum (Sigma, St. Louis, MO)
was purchased and placed into a bottle coated with a substance
that cuts out ultraviolet light. The bottles were diluted to 30%
with PBS. The bottles were maintained in a refrigerator at 4 °C
while in use.
Alkali burn animal model: Thirty male Sprague-Dawley rats
(weight range, approximately 250–300 g) were used in this
study. All of the animals were treated in accordance with the
guidelines laid out in the Association for Research in Vision
and  Ophthalmology  (ARVO)  Statement  for  the  Use  of
Animals  in  Ophthalmic  and  Vision  Research,  and  were
approved by the Committee for Animal Research, Catholic
University of Medicine. The rats were deeply anesthetized via
the intraperitoneal injection of 50 mg/kg of tiletamine plus
zolazepam (Zoletil; Virbac, Carros, France) and 15 mg/kg of
xylazine  hydrochloride  (Rompun;  Bayer,  Leuverkeusen,
Germany). Alkali injuries to the right eyes were induced via
60 s of exposure of the central cornea to a 4 mm diameter disk
of filter paper soaked in 1 N NaOH, followed by rinsing with
sterile  saline  (10  ml).  The  animals  were  then  randomly
allocated  into  three  treatment  groups.  The  control  group
(n=10) was treated topically with PBS, four times a day,
immediately after alkali injury, for a total period of 2 days.
The first study group (n=10) was treated topically with a 30%
AM  suspension,  and  the  second  study  group  (n=10)  was
treated  topically  with  a  30%  rat  serum.  Via  slit  lamp
biomicroscopy  (SL-15;  kowa,  Tokyo,  Japan),  the  injured
corneas were then evaluated and scored as described in detail
below. Photographs of fluorescein-stained corneas at initial
wounding and 48 h after the induction of the alkali burn were
obtained to measure the area of the epithelial defect. The area
of  the  corneal  scrape  wound  was  quantified  from  the
photographs  using  a  computer-assisted  image  analyzer
(Image J 1.38x; National Institutes of Health, Bethesda, MD).
The extent of healing was determined by the ratio of the
difference between the zero hour and the remaining wound
areas after 48 h.
Scoring  for  corneal  opacity  and  neovascularization:  A
previously described scoring system [8] was employed to
measure the degree of corneal opacification between 0 to 5+:
0=clear and compact cornea; 1+=minimal superficial opacity;
2+=mild deep (stromal) opacity with pupil margin and iris
vessels visible; 3+=moderate stromal opacity with only pupil
margin  visible;  4+=intense  stromal  opacity  with  anterior
chamber  visible;  5+=maximal  corneal  opacity  with  total
obscuration  of  the  anterior  chamber.  Corneal
neovascularization (NV) was graded between 0 and 3 per
corneal quadrant, with increments of 0.5, using a grid system
based  on  the  centripetal  extent  of  neovascular  branch
outgrowth from the corneoscleral limbus [9]. Dilated limbal
vessels not penetrating the corneal stroma were not considered
representative of corneal NV. All gradings were conducted in
a masked fashion. The scores for each quadrant were then
summed to derive the corneal NV indices (range, 0–12) for
each eye at a given time point [9]. The mean differences in
corneal  opacities  and  corneal  NV  scores  were  compared
among each group.
Histologic documentation of inflammatory cell infiltration:
The 30 rats were killed after the clinical examination, and for
histological  evaluation,  three  eyes  in  each  group  were
randomly  selected  and  enucleated  and  fixated  in  4%
formaldehyde.  Corneas  were  sectioned  centrally  and
embedded in paraffin, and 5 μm sections were stained with
hematoxylin  and  eosin.  Next,  for  immunohistochemical
evaluation,  the  tissues  were  fixed  for  20  min  at  room
temperature (RT) and blocked for 1 h with 2% bovine serum
albumin. Rat anti-F4/80 antibody (a macrophage marker) was
employed to evaluate the acute inflammatory reaction; this
antibody  (1:1,000;  Sigma  Aldrich,  St.Louis,  MO)  was
administered and incubated for 1 h at RT. The slides were
washed three times with PBS and incubated for 1 h at RT with
goat-anti-mouse-Alexa 546 (Invitrogen, Carlsbad, CA). The
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405Figure 1. Corneal epithelial wound healing immediately and 48 h after alkali burn. A: The control group, immediately after alkali burn. B:
The control group, 48 h after alkali burn. C: AM suspension group, immediately after alkali burn. D: AM suspension group, 48 h after alkali
burn. E: Serum eyedrop group, immediately after alkali burn. F: Serum eyedrop group, 48 h after alkali burn. The figure is representative of
the experiments. In the control group, the wound immediately after alkali burn (A) was not changed after 48 h (B). However, in the AM
suspension group, the wound immediately after alkali burn (C) was decreased after 48 h (D). Furthermore, in the serum eyedrop group, the
wound immediately after alkali burn (E) was decreased after 48 h (F). The wound healing ratio (G) was significantly higher in the AM
suspension and serum eyedrop groups than the control group (p<0.001). The difference between the AM suspension and serum eyedrop groups
was not statistically significant (p=0.458).
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406cells were rinsed with PBS, and the nuclei were counterstained
with Hoechst 33342 (1:500) for 10 min at RT. The samples
were observed under a fluorescence microscope (Axiovert
200; Carl Zeiss Inc., Göttingen Germany). For the comparison
of these study samples with the natural state of the cornea, the
rat corneas without alkali burns were treated via the same
method as described above.
Statistical analysis: We confirmed all observations via several
different experiments. The data were compared with each
group and expressed as means±standard deviation (SD). All
statistical  data  were  analyzed  via  one-way  Analysis  of
Variance  (SPSS  13.0)  and  Bonferonni’s  multiple
comparisons; results were considered significant at p<0.05.
RESULTS
Corneal epithelial wound healing in alkali burn: Figure 1
shows corneal epithelial wound healing immediately and 2
days  after  alkali  burn  in  the  control  (PBS)  group,  AM
suspension  group,  and  serum  eye  drop  group;  the  results
shown are representative of the experiments. In the control
group (Figure 1A,B), 1.8±5.1% of the alkali burn wound was
recovered, whereas the AM suspension (Figure 1C,D) and
serum  eyedrop  groups  (Figure  1E,F)  evidenced  wound
healing rates of 34.1±7.7% and 41.5±6.1%, respectively. The
control  group  exhibited  a  wound  healing  rate  that  was
significantly lower than that of the other two study groups
(p<0.001), and the difference between the AM suspension and
serum  eyedrop  group  was  not  found  to  be  statistically
significant. (p=0.458; Figure 1G).
Corneal  opacity  and  neovascularization:  The  scores  for
corneal opacity developing after alkali burn were 4.75±.46,
3.40±.51, and 3.00±.76 in the control, AM suspension, and
serum eyedrop groups, respectively (Figure 2). The control
group exhibited a corneal opacity score that was significantly
higher than those of the other two study groups (p<0.001),
while the difference between the AM suspension and serum
eyedrop groups was not found to be statistically significant
(p=0.491). Additionally, the scores for the NV developed after
alkali  burn  were  5.75±.89,  4.00±.33,  and  4.25±.88  in  the
control,  AM  suspension,  and  serum  eyedrop  groups,
respectively. The control group evidenced a corneal opacity
score that was significantly higher than those of the two study
groups  (p=0.006),  while  the  difference  between  the  AM
suspension and serum eyedrop groups was not found to be
statistically significant (p>0.05).
Histologic documentation of inflammatory cell infiltration:
Light microscopic findings in the control, AM suspension,
serum  eyedrop,  and  comparison  groups  without  any
manipulation 48 h after alkali burn are shown in Figure 3. The
corneal  thickness  was  greatly  increased  and  many
polymorphonuclear  leukocytes  infiltrated  into  the  corneal
stroma in the control group (Figure 3A). However, relatively
fewer  polymorphonuclear  leukocytes  infiltrated  into  the
cornea in the AM suspension (Figure 3B) and serum eyedrop
groups (Figure 3C) compared to the control group. In addition,
the corneal thicknesses were slightly increased in the AM
suspension (Figure 3B) and serum eyedrop groups (Figure
3C)  compared  to  the  comparison  group  without  any
manipulation  (Figure  3D).  In  immunocytochemistry  for
mouse F4/80 antigen, large quantities of F4/80+ cells were
noted in the control group (Figure 4A,B), particularly in the
corneal limbal region. By way of contrast, we noted minimal
F4/80 expression in the AM suspension (Figure 4C,D) and
serum eyedrop groups (Figure 4E,F). Numbered stained cells
were 163.7±1.2, 76.4±1.8, 87.0±9.0, 7.3±.8 in the control, AM
Figure  2.  Corneal  opacity  and
neovascularization  (NV)  scores  48  h
after alkali burn. In the opacity score, the
amniotic  membrane  (AM)  suspension
and  serum  eyedrop  groups  showed
significantly lower scores compared to
the control group (p<0.001). In addition,
in the NV score, the AM suspension and
serum  eyedrop  groups  also  showed
significantly lower scores compared to
the control group (p=0.006).
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407suspension, serum eyedrop, and comparison group without
any manipulation (p=0.027; Figure 5).
DISCUSSION
Failure of the ocular surface occurs in a broad range of clinical
conditions,  with  differing  pathogeneses.  Ocular  surface
diseases  also  frequently  prove  to  be  nonresponsive  to
conventional  treatments,  including  topical  therapy  (ocular
lubricants),  therapeutic  contact  lenses,  phototherapeutic
lasers, medical (botulinum toxin) or surgical (stitching the lids
together)  tarsorrhaphy,  protective  glasses,  etc  [10].  In  the
treatment  of  nonresponsive  ocular  surface  disease,  serum
eyedrops, AM transplantation, and limbal epithelial stem cell
grafts  represent  three  recent  advances  [1].  Among  these
emerging  tools,  serum  eyedrops  harbor  an  abundance  of
epitheliotropic factors present in tears, and these eyedrops are
widely employed in the treatment of dry eye disease [10].
Despite  their  proven  efficacy  [10,11]  in  dry  eye  disease,
however, topical autologous serum eyedrops may be limited
in  several  ways.  Fox  et  al.  [12]  previously  reported  and
described  a  case  of  scleral  vasculitis  in  a  patient  with
rheumatoid arthritis that arose after serum eyedrop treatment.
Conjunctivitis was also found in other case reports [13,14].
Conjunctivitis may prolong or aggravate ocular infections
because serum contains an abundance of nutrients, as shown
in cases of Candida infectious crystalline keratopathy and
Figure 3. Light microscopic findings 48 h after alkali burn at 100× magnification. A: The control group and B: amniotic membrane (AM)
suspension group. C: Serum eyedrop group and D: comparison group without any manipulation. The figure is representative of the experiments.
The corneal thickness was greatly increased and many polymorphonuclear leukocytes infiltrated into the corneal stroma in the control group
(A). However, relatively fewer polymorphonuclear leukocytes infiltrated into the cornea in the AM suspension (B) and serum eyedrop groups
(C). Note that the comparison group without any manipulation (D) shows normal corneal thickness without any polymorphonuclear leukocytes
infiltration.
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408Figure 4. Immunohistochemical staining 48 h after alkali burn at 100× magnification. A, B: The control group; C, D: the amniotic membrane
(AM) suspension group; E, F: the serum eyedrop group; and G, H: the comparison group without any manipulation. The figure is representative
of the experiments. Cell nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI; blue; A, C, E, F), and the F4/80 expressions (red)
on the section of cornea 48 h after alkali burn were noted (B, D, F, H) The amount of F4/80 expression was largest in the control group.
However, F4/80 expression is hardly seen in the AM suspension and serum eyedrop groups. Note that there is no expression of F4/80 in the
comparison group without any manipulation.
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409coagulase-negative staphylococcus keratitis in patients with
persistent  epithelial  defects  following  serum  eyedrop
treatment [15]. Additionally, owing to its immunogenicity,
only autologous serum can be employed; this precludes its use
in patients with hemoglobinopathies, elevated total protein
and  albumin  levels,  or  taking  medications  that  may  be
injurious to the cornea, as well as in patients with positive
microbial serology [10].
The  use  of  topical  steroids  profoundly  reduces
inflammatory reactions, but interferes with the process of
wound  repair,  thereby  exacerbating  the  risk  of  corneal
ulceration  and  perforation  [16].  However,  AM  has  both
epithelialization and anti-inflammation properties; this has
been demonstrated in previous clinical studies concerning
AM transplantation [5-7]. Furthermore, AM has been shown
to possess antibacterial properties [17,18]. Gicquel et al. [19]
reported  previously  that  early  AM  transplantation  can  be
employed  as  a  safe  adjuvant  therapy  during  antibacterial
treatment in cases of severe bacterial keratitis. Therefore, if
AM is prepared in eyedrop form and maintains its effects, it
may constitute a potent clinical tool for the treatment of ocular
surface  disease.  In  our  previous  study,  the  authors
demonstrated that the AM suspension exerts a positive effect
on corneal re-epithelialization according to its concentration
in a simple in vitro wound healing model [20]. In the present
study, we attempted to show that the anti-inflammatory effect
of AM is maintained when AM is applied in suspension form
in an animal model.
To prepare the inflammatory wound model, we induced
an alkali injury to the rat corneas using 1 N NaOH. The
concentration (30%) of the AM suspension was determined
from  the  results  of  our  previous  study  [20],  and  the
concentration of rat serum was set to 30%, which was identical
to that of the AM suspension, to compare the actual effects of
the two eyedrops.
In terms of re-epithelialization, both the AM suspension
and serum eyedrop groups evidenced significantly more rapid
healing than was observed in the control group (Figure 1).
Additionally, with regard to its anti-inflammatory effect, the
AM  suspension  and  serum  eyedrops  suppressed  acute
inflammatory reactions, as was revealed by the results of
immunochemical  assays  using  F4/80  (mouse  macrophage
marker; Figure 4). Lower F4/80 expression was noted in the
AM  suspension  and  serum  eyedrop  group  relative  to  the
control  group,  which  evidenced  relatively  high  F4/80
expression.  These  groups  also  evidenced  significantly
suppressed corneal opacity and NV relative to the control
group  (Figure  2).  In  our  pilot  study  before  the  full-scale
experiment,  the  epithelialization  was  almost  completed  in
both study groups at approximately 48 h after the alkali burn.
Therefore,  we  established  a  follow-up  period  of  48  h  to
evaluate both epithelialization and anti-inflammation effects.
Figure  5.  Numbers  of  stained  cells
expressing  F4/80  on  the  section  of
cornea  48  h  after  alkali  burn.  The
number  of  stained  cells  was
significantly higher in the control group
compared  to  the  AM  suspension  and
serum eyedrop group. (p=0.027) Note
there were almost no stained cells in the
comparison  group  without  any
manipulation.
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410However, to assess late sequelae of the chemical burns, studies
with longer follow-up periods are warranted.
Although the AM suspension exhibited a significantly
rapid healing rate relative to the control group, we noted no
significant differences between the serum eyedrop and AM
suspension groups. In this study, commercial sterile rat serum
was  used  to  prevent  immunogenicity,  whereas  AM  was
obtained  from  humans.  The  xenogenicity  of  the  AM
suspension might have had some influence on the results.
Additionally, substances that modulate epithelialization are
abundant in serum eyedrops, as well as in AM suspension
[10].  In  this  study,  serum  treatment  was  also  shown  to
ameliorate acute inflammatory reactions as in AM suspension.
Therefore,  in  addition  to  its  epitheliotropic  effect,  serum
appears to exert some anti-inflammatory effects, although the
mechanism underlying the anti-inflammatory effects of serum
have yet to be elucidated.
In  conclusion,  the  AM  suspension  used  herein  was
determined to enhance epithelial healing and reduce corneal
opacity  and  NV  in  inflammatory  corneal  wounds;  it  also
suppressed the expression of F4/80 in the corneal stroma,
thereby indicating that the suspension form of AM maintains
anti-inflammatory  effects  comparable  to  those  of  serum
eyedrops. With its non-immunogenicity and relatively low
risk  of  possible  infection,  AM  suspension  appears  to
constitute a valuable clinical technique for the treatment of
symptoms associated with intractable inflammatory ocular
surface disease, including severe dry eye, chemical burns, and
persistent epithelial defects.
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